CAS: 509077-99-0 - Ertumaxomab
Fórmula:Unspecified
- Sinónimos:
- Immunoglobulin G2a, anti-(human HER-2/neu) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Immunoglobulin G2a, anti-(human neu (receptor)) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Immunoglobulin G2a, anti-(human c-erbB2 (receptor)) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Ertumaxomab
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Ertumaxomab REF: 3D-CLA1169CAS: 509077-99-0 | - - - | A consultar | Lun 04 Nov 24 |
Ertumaxomab
CAS:509077-99-0
Anti-human CD22 recombinant antibody bispecific antibody targeting HER2/neu and CD3.
Ref: 3D-CLA1169
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Lunes 4 de Noviembre de 2024
